These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 8412310

  • 1. A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
    Lee EJ, Reck K, Carter C, Hodges S, Schiffer CA.
    Leukemia; 1993 Oct; 7(10):1500-3. PubMed ID: 8412310
    [Abstract] [Full Text] [Related]

  • 2. Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia.
    Lee EJ, Reck K, Schiffer CA.
    Leukemia; 1990 Mar; 4(3):189-92. PubMed ID: 2314118
    [Abstract] [Full Text] [Related]

  • 3. Phase I study of continuous infusion 6-thioguanine in patients with acute leukemia.
    Powell BL, Lyerly ES, Motsinger CP, Cruz JM, Chorley HM, Hurd DD, Cooper MR.
    Leukemia; 1995 May; 9(5):770-3. PubMed ID: 7769838
    [Abstract] [Full Text] [Related]

  • 4. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
    Amadori S, Picardi A, Fazi P, Testi AM, Petti MC, Montefusco E, Mandelli F.
    Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
    Kantarjian HM, Beran M, O'Brien S, Robertson L, Siddik Z, Yoshida M, Yang LY, Rios MB, Keating MJ, Meyer M.
    Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
    [Abstract] [Full Text] [Related]

  • 6. Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia.
    Letendre L, Noel P, Tefferi A, Solberg LA, Gastineau DA, Hoagland HC.
    Am J Clin Oncol; 1995 Oct; 18(5):382-4. PubMed ID: 7572751
    [Abstract] [Full Text] [Related]

  • 7. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R, Guardia R, Altés A, Sureda A, Brunet S, Sierra J.
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
    Feldman EJ, Alberts DS, Arlin Z, Ahmed T, Mittelman A, Baskind P, Peng YM, Baier M, Plezia P.
    J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
    Schlenk RF, Hartmann F, Hensel M, Jung W, Weber-Nordt R, Gabler A, Haas R, Ho AD, Trümper L, Döhner H.
    Leukemia; 2002 Apr; 16(4):581-6. PubMed ID: 11960336
    [Abstract] [Full Text] [Related]

  • 18. Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study.
    Sadowitz PD, Dubowy R, Souid A, Pollock BH, Weinstein H, Parmley RT, Bowman WP, Land V, Vats T, Pratt C.
    J Clin Oncol; 1994 Sep; 12(9):1969-73. PubMed ID: 8083718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.